We are live on ! Find out more
Bank of New York Mellon

Bank of New York Mellon Portfolio holdings

AUM $609B
1-Year Est. Return 40.19%
 

Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.

This Fund
S&P 500
This Quarter Est. Return
+8.51%
1 Year Est. Return
+40.19%
3 Year Est. Return
+118.86%
5 Year Est. Return
+156%
10 Year Est. Return
+606.23%
AUM
$517B
AUM Growth
+$27.6B
Cap. Flow
-$8.37B
Cap. Flow %
-1.62%
Top 10 Hldgs %
19.4%
Holding
4,590
New
277
Increased
1,772
Reduced
2,129
Closed
201

Top Sells

Rank Stock Value
1
FERG icon
Ferguson
FERG
+$692M
2
LIN icon
Linde
LIN
+$624M
3
MDT icon
Medtronic
MDT
+$527M
4
GS icon
Goldman Sachs
GS
+$340M
5
MSFT icon
Microsoft
MSFT
+$301M

Sector Composition

Rank Sector Weight
1 Technology 25.11%
2 Healthcare 13.18%
3 Financials 12.45%
4 Consumer Discretionary 10.8%
5 Communication Services 8.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DCOY
4226
Decoy Therapeutics
DCOY
$1.92M
$38K ﹤0.01%
1
RENO
4227
DELISTED
Renovare Environmental, Inc. Common Stock
RENO
$38K ﹤0.01%
26,044
-4,748
-15% -$6.75K
GNCA
4228
DELISTED
Genocea Biosciences, Inc.
GNCA
$38K ﹤0.01%
16,305
-2,535
-13% -$6.11K
HNRG icon
4229
Hallador Energy
HNRG
$726M
$37K ﹤0.01%
13,588
EVFM
4230
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
$37K ﹤0.01%
2,175
-14,784
-87% -$280K
DOMH icon
4231
Dominari Holdings
DOMH
$70.5M
$36K ﹤0.01%
2,199
-400
-15% -$6.85K
PRPO icon
4232
Precipio
PRPO
$40.8M
$36K ﹤0.01%
+500
New +$32.8K
COMS
4233
DELISTED
COMSovereign Holding Corp. Common Stock
COMS
$36K ﹤0.01%
154
-29
-16% -$6.74K
RVLP
4234
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
$36K ﹤0.01%
12,078
-34,468
-74% -$105K
CLRB icon
4235
Cellectar Biosciences
CLRB
$20.5M
$34K ﹤0.01%
95
MCHX icon
4236
Marchex
MCHX
$76.2M
$34K ﹤0.01%
11,245
ATXS
4237
DELISTED
Astria Therapeutics
ATXS
$32K ﹤0.01%
2,549
-7,972
-76% -$104K
ACER
4238
DELISTED
Acer Therapeutics Inc
ACER
$32K ﹤0.01%
11,133
-1,573
-12% -$4.53K
DNN icon
4239
Denison Mines
DNN
$2.96B
$31K ﹤0.01%
+26,301
New +$31.6K
SNGX icon
4240
Soligenix
SNGX
$8.43M
$31K ﹤0.01%
116
+8
+7% +$2.34K
MIND icon
4241
MIND Technology
MIND
$42.9M
$29K ﹤0.01%
1,471
OGI
4242
Organigram Holdings
OGI
$179M
$29K ﹤0.01%
+2,525
New +$28.7K
PHUN icon
4243
Phunware
PHUN
$43.2M
$29K ﹤0.01%
424
-552
-57% -$40.4K
RMTI icon
4244
Rockwell Medical
RMTI
$29M
$29K ﹤0.01%
293
-1,832
-86% -$189K
SALM
4245
DELISTED
Salem Media Group, Inc. Class A Common Stock
SALM
$29K ﹤0.01%
11,380
OPGN
4246
DELISTED
OpGen, Inc
OPGN
$28K ﹤0.01%
62
-11
-15% -$5.03K
IMNN icon
4247
Imunon
IMNN
$6.64M
$27K ﹤0.01%
110
MOTS
4248
DELISTED
Motus GI Holdings, Inc. Common Stock
MOTS
$25K ﹤0.01%
79
-14
-15% -$4.56K
SCTL
4249
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
$24K ﹤0.01%
10,526
-50,673
-83% -$129K
ELOX
4250
DELISTED
Eloxx Pharmaceuticals, Inc. Common Stock
ELOX
$24K ﹤0.01%
298
-1,484
-83% -$124K

Similar funds

Bank of New York Mellon's Q2 2021 Portfolio in Review

As of Q2 2021, Bank of New York Mellon held 4,590 positions worth $517B, up 5.6% from $489B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Bank of New York Mellon's Q2 2021 filing shows 277 new, 1,772 increased, 2,129 reduced and 201 closed positions. Its largest new stake was Organon & Co: 4,240,135 shares worth $128M. The largest sale was Ferguson, an estimated $692M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.

  • Bank of New York Mellon's largest Q2 2021 buy was Organon & Co: 4,240,135 shares worth $128M.
  • Bank of New York Mellon added most to Vanguard FTSE Developed Markets ETF in Q2 2021, an estimated $307M increase.
  • Bank of New York Mellon's biggest Q2 2021 reduction was Ferguson, cutting an estimated $692M.
  • Bank of New York Mellon fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $164M.
  • Bank of New York Mellon's ten largest holdings make up 19% of its $517B portfolio in Q2 2021.
  • Bank of New York Mellon opened 277 new positions and closed 201 in Q2 2021.
  • Bank of New York Mellon's portfolio value rose 5.6% quarter-over-quarter to $517B.

Based on Bank of New York Mellon's 13F filing for Q2 2021, filed 11 Aug 2021.